Abstract:Background: Liver cancer stem cells (CSCs) are critical determinants of HCC relapse and therapeutic resistance, but the mechanisms underlying the maintenance of CSCs are poorly understood. We aimed to explore the role of tumor repressor Zinc-fingers and homeoboxes 2 (ZHX2) in liver CSCs. Methods: CD133(+) or EPCAM(+) stem-like liver cancer cells were sorted from tumor tissues of HCC patients and HCC cell lines by flow cytometry. In addition, sorafenib-resistant cells, tumor-sphere forming cells and side population (SP) cells were respectively cultured and isolated as hepatic CSCs. The tumor-initiating and chemoresistance properties of ZHX2-overexpressing and ZHX2-knockdown cells were analyzed in vivo and in vitro. Microarray, luciferase reporter assay, chromatin immunoprecipitation (ChIP) and ChIP-on-chip analyses were performed to explore ZHX2 target genes. The expression of ZHX2 and its target gene were determined by quantitative RT-PCR, western blot, immunofluorescence and immunohistochemical staining in hepatoma cells and tumor and adjacent tissues from HCC patients. Results: ZHX2 expression was significantly reduced in liver CSCs from different origins. ZHX2 deficiency led to enhanced liver tumor progression and expansion of CSC populations in vitro and in vivo. Re-expression of ZHX2 restricted capabilities of hepatic CSCs in supporting tumor initiation, self-renewal and sorafenib-resistance. Mechanically, ZHX2 suppressed liver CSCs via inhibiting KDM2A-mediated demethylation of histone H3 lysine 36 (H3K36) at the promoter regions of stemness-associated transcription factors, such as NANOG, SOX4 and OCT4. Moreover, patients with lower expression of ZHX2 and higher expression of KDM2A in tumor tissues showed significantly poorer survival. Conclusion: ZHX2 counteracts stem cell traits through transcriptionally repressing KDM2A in HCC. Our data will aid in a better understanding of molecular mechanisms underlying HCC relapse and drug resistance. (c) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Krüppel‐like Factor 2 Inhibits Hepatocarcinogenesis Through Negative Regulation of the Hedgehog Pathway

KLF4 Downregulates Htert Expression and Telomerase Activity to Inhibit Lung Carcinoma Growth.

KLF2 Inhibits TGF-β-mediated Cancer Cell Motility in Hepatocellular Carcinoma

Kruppel-Like Factor 6 Suppresses Growth and Invasion of Hepatocellular Carcinoma Cells in Vitro and in Vivo

Alterations of Krüppel-like Factor Signaling and Potential Targeted Therapy for Hepatocellular Carcinoma

Krüppel‐like Factor 8 Promotes Cancer Stem Cell‐like Traits in Hepatocellular Carcinoma Through Wnt/β‐catenin Signaling

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

Kruppel-Like Factor 8 Is A New Wnt/Beta-Catenin Signaling Target Gene And Regulator In Hepatocellular Carcinoma

A novel role of Krüppel-like factor 8 as an apoptosis repressor in hepatocellular carcinoma

A Negative Feedback Loop Between KLF9 and the EMT Program Dictates Metastasis of Hepatocellular Carcinoma.

Up-regulation of Krüppel-like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Zinc Fingers and Homeoboxes 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Represses Expression of Cyclins A and E

Klf4-Mediated Cdh3 Upregulation Suppresses Human Hepatoma Cell Growth And Migration Via Gsk-3 Beta Signaling

Inactivation of the Tumor Suppressor Krüppel-like Factor 6 (KLF6) by Mutation or Decreased Expression in Hepatocellular Carcinomas

Linc-KILH Potentiates Notch1 Signaling Through Inhibiting KRT19 Phosphorylation and Promotes the Malignancy of Hepatocellular Carcinoma.

ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation

Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells by Krüppel-like Factor 4.

Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression Through Activation of Hepatocyte Nuclear Factor-6.

Dysregulated Krüppel-like Factor 4 and Vitamin D Receptor Signaling Contribute to Progression of Hepatocellular Carcinoma.

KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells

The Long Non-Coding RNA LncHDAC2 Drives the Self-Renewal of Liver Cancer Stem Cells Via Activation of Hedgehog Signaling.